CD44 and breast carcinoma: Cluster determinant 44 (CD44) is a cell surface glycoprotein receptor highly expressed in tumours such as lung, pancreatic, and breast cancers, particularly known in promoting breast cancer metastasis to the liver.26 Targeting CD44 for anticancer therapy offers a promising approach.